Barry W. Weiner
Net Worth

Last updated:

What is Barry W. Weiner net worth?

The estimated net worth of Mr. Barry W. Weiner is at least $16,239,818 as of 14 Jan 2019. He owns shares worth $408,602 as insider, has earned $637,296 from insider trading and has received compensation worth at least $15,193,920 in Enzo Biochem, Inc..

What is the salary of Barry W. Weiner?

Mr. Barry W. Weiner salary is $723,520 per year as Founder, Treasurer & Pres in Enzo Biochem, Inc..

How old is Barry W. Weiner?

Mr. Barry W. Weiner is 75 years old, born in 1950.

What stocks does Barry W. Weiner currently own?

As insider, Mr. Barry W. Weiner owns shares in one company:

Company Title Shares Price per share Total value
Enzo Biochem, Inc. (ENZ) Founder, Treasurer & Pres 1,302,111 $0.31 $408,602

What does Enzo Biochem, Inc. do?

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing 'STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in New York, New York.

ENZ logo
ENZ
Enzo Biochem, Inc.
$0.31

Barry W. Weiner insider trading

Enzo Biochem, Inc.

Mr. Barry W. Weiner has made 3 insider trades between 2004-2019, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 201,014 units of ENZ stock on 26 Apr 2004. As of 14 Jan 2019 he still owns at least 1,302,111 units of ENZ stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (to acquire common stock) 33,305 $2.7 $89,924
Option
Common Stock 2,226 $2.7 $6,010
Option
Stock Option (to aquire common stock) 30,802 $2.88 $88,710
Sale
Common Stock 11,000 $7.75 $85,250
Option
Common Stock 30,802 $2.88 $88,710
Sale
Common Stock 54,126 $10.11 $547,214
Option
Stock Option (to acquire common stock) 112,500 $3 $337,500
Option
Common Stock 112,500 $3 $337,500
Purchase
Common Stock, par value $0.01 per share 20,000 $2.3 $45,940
Purchase
Common Stock, par value $0.01 per share 20,000 $2.3 $45,940
Option
Employee Stock Option 60,755 $5.45 $331,115
Option
Common Stock, par value $0.01 per share 60,755 $5.45 $331,115
Option
Common Stock, par value $.01 per share 67,005 $11.01 $737,524
Option
Common Stock, par value $.01 share 201,014 $7.37 $1,481,272
Option
Common Stock, par value $.01 per share 201,014 $7.37 $1,481,272
Sale
Common Stock, par value $.01 per share 300 $16.11 $4,832

Enzo Biochem key executives

Enzo Biochem, Inc. executives and other stock owners filed with the SEC: